Skip to main content
Log in

Androgen receptors, serum androgen levels and survival of breast cancer patients

  • Originals
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

Summary

Steroid receptor levels and serum androgen levels were determined in 61 breast cancer patients and 34 patients with non-malignant breast lesions. Testosterone and dehydroepiandrosterone-sulfate did not and androstenedione did show a difference between the two groups. Androgen levels had no influence on survival rates. Androgen receptor (AR) levels correlated with progesterone receptor levels, but not with estrogen receptor levels or with tumor stage. Patients with positive AR findings had a better survival rate; this was independent of tumor stage. AR findings may therefore be a prognostic index in breast cancer patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Allegra JC, Lippman ME, Thompson EB et al. (1979) Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer. Cancer Res 39:1447–1451

    CAS  PubMed  Google Scholar 

  2. Bezwoda WR, Mansoor N, Dansey R, Esser JD (1987) Aromatisation of androstenedione by human breast cancer tissue: Correlation with hormone receptor activity and possible biologic significance. Oncology 44:30–33

    CAS  PubMed  Google Scholar 

  3. Bonadonna G, Brusamolino E, Valagussa P (1976) Combination chemotherapy as an adjuvant treatment in operable cancer. N Engl J Med 294:405

    CAS  PubMed  Google Scholar 

  4. Brentani MM, Franco EL, Oshima CT, Pacheco MM (1986) Androgen, estrogen, and progesterone receptor levels in malignant and benign breast tumors: a multivariate analysis approach. Int J Cancer 36:639–642

    Google Scholar 

  5. Bryan RM, Mercer RJ, Bennett RC, Rennie GC, Lie TH, Morgan FJ (1984) Oestradiol receptor values in breast cancer and response of metastases to therapy. Aust NZ J Surg 54:3–6

    CAS  Google Scholar 

  6. Bryan RM, Mercer RJ, Bennett RC, Rennie GC, Lie TH, Morgan FJ (1984) Androgen receptors in breast cancer. Cancer 54:2436–2440

    CAS  PubMed  Google Scholar 

  7. Cox DR (1972) Regression models and life tables. J Roy Statist Soc 34:187–220

    Google Scholar 

  8. Cuzcik J (1982) Rank tests for association with right censored data. Biometrika 69:351–364

    Google Scholar 

  9. Dixon WJ (ed) (1987) BMDP Biomedical computer programs. University of California Press, Berkeley

    Google Scholar 

  10. Grill HJ, Manz B, Belovsky O, Pollow K (1984) Criteria for the establishment of a double-lab assay for simultanous determination of estrogen and progesterone receptors. Oncology 41:25–32

    CAS  PubMed  Google Scholar 

  11. Grill HJ, Moebius U, Manz B, Pollow K (1983) Determination of androgen receptors. Steroid Biochem 19:1687

    CAS  Google Scholar 

  12. Henderson JC, Mouridsen H, Breast Cancer Collaborative Group (1988) Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. N Engl J Med 319:1681–1692

    Google Scholar 

  13. Horn H, Gordan GS (1974) Plasma testosterone in advanced breast cancer. Oncology 30:147–151

    CAS  PubMed  Google Scholar 

  14. Lippmann, ME (1980) Steroid receptor analyses and endocrine therapy of breast cancer. In: Bresciani F (ed) Perspectives in steroid receptor research. Raven Press, New York

    Google Scholar 

  15. Malarkey WB, Schroeder LL, Stevens VC, James AG, Lanese RR (1977) Twenty-four-hour preoperative endocrine profiles in women with benign and malignant breast disease. Cancer Res 37:4655–4659

    CAS  PubMed  Google Scholar 

  16. McGuire WL (1978) Hormone receptors: their role in predicting prognosis and response to endocrine therapy. Semin Oncol 5:428–433

    CAS  PubMed  Google Scholar 

  17. Miller WR, Telford J, Dixon JM, Hawkins RA (1985) Androgen receptor activity in human breast cancer and its relationship with oestrogen and progestogen receptor activity. Eur J Cancer Clin Oncol 21:539–544

    Article  CAS  PubMed  Google Scholar 

  18. Persijn JP, Korsten CB, Engelsman E (1975) Oestrogen and androgen receptors in breast cancer and response to endocrine therapy. Br Med J 4:503

    CAS  PubMed  Google Scholar 

  19. Pollow K, Schweikhart G, Mitze M (1982) Verteilung von Östradiol-, Progesteron-, Androgen-und Glukokortikoidrezeptoren in Mammacarcinomen der Frau. In: Jonat W, Maass H (eds) Steroidhormonrezeptoren im Karzinomgewebe. Enke Verlag, Stuttgart

    Google Scholar 

  20. Reiner G, Bieglmayer Ch, Jakesz R, Kolb R, Spona J (1979) Estradiol and progesterone receptor levels in human breast carcinomas in relation to hormone serum levels in postmenopausal women. Cancer Treat Rep 63:1185

    Google Scholar 

  21. Reiner G, Jakesz R, Kolb R, Kühnl-Brady K, Reiner A, Schemper M, Spona J (1988) Androgenrezeptoren beim primären Mammakarzinom. Dtsch Med Wochenschr 113:892–897

    CAS  PubMed  Google Scholar 

  22. Rose LI, Underwood RH, Dunning MT, Williams GH, Pinkus GS (1975) Testosterone metabolism in benign and malignant breast lesions. Cancer 36:399–403

    CAS  PubMed  Google Scholar 

  23. Scatchard G (1949) The attraction of proteins for small molecules and ions. Ann NY Acad Sci 51:660

    CAS  Google Scholar 

  24. Secreto G, Fariselli G, Bandieramonte G, Recchione C, Dati V, DiPietro S (1983) Androgen excretion in women with a family history of breast cancer or with epithelial hyperplasia of the breast. Eur J Cancer Clin Oncol 19:5–10

    Article  CAS  PubMed  Google Scholar 

  25. Trams G, Maass H (1977) Specific binding of estradiol and dihydrotestosterone in human mammary cancers. Cancer Res 37:258

    CAS  PubMed  Google Scholar 

  26. Wang DY, Moore JW, Thomas BS, Bulbrook RD, Hoare SA, Tong D, Hayward JL (1979) Plasma and urinary androgens in women with varying degrees of risk of breast cancer. Eur J Cancer 15:1269–1274

    CAS  PubMed  Google Scholar 

  27. Zielinski Ch, Kuzmits R, Kubista E, Salzer H, Staffen A, Aiginger P, Spona J (1985) Die Bedeutung der Hormonrezeptoren von Mammakarzinomzellen für die Dauer des erkrankungsfreien Intervalls. Wi Kli Wochenschr 97/11:493–497

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Langer, M., Kubista, E., Schemper, M. et al. Androgen receptors, serum androgen levels and survival of breast cancer patients. Arch Gynecol Obstet 247, 203–209 (1990). https://doi.org/10.1007/BF02389545

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02389545

Key words

Navigation